Sphere formation assay was carried out as reported previously [24 (link)]. Concisely, transfected MDA-MB-231 or MCF-7 cells were inoculated in ultra-low attachment 6-well plates (Corning, NY, USA; 5 × 103 cells per well) for 10–14 days. Cells were maintained in DMEM/F12 serum-free medium (PM150312A, Procell) added with 5 μg/mL insulin (Sigma-Aldrich), 0.4% bovine serum albumin (BSA; A1933, Sigma-Aldrich), 2% B27 (MAB1285, Sigma-Aldrich), 20 ng/mL basic fibroblast growth factor (bFGF; PHG0369, Thermo Fisher Scientific), and 20 ng/mL EGF (Peprotech, Rocky Hill, NJ, USA). Generated spheres were photographed and then counted using a light microscope (Zeiss, Oberkochen, Germany). Sphere formation efficiency is calculated as (number of spheres/number of inoculated cells) × 100%, using MShot Image Analysis System. Only spheres with diameters greater than 75 μm were counted.
Free full text: Click here